Your browser doesn't support javascript.
loading
Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis.
Peleg Hasson, S; Brezis, M R; Shachar, E; Shachar, S S; Wolf, I; Sonnenblick, A.
Affiliation
  • Peleg Hasson S; Oncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Brezis MR; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shachar E; Oncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shachar SS; Oncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Wolf I; Oncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Sonnenblick A; Oncology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: amirson@tlvmc.gov.il.
ESMO Open ; 6(2): 100088, 2021 04.
Article in En | MEDLINE | ID: mdl-33735801

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country: Country of publication: